Диссертация (1141028), страница 17
Текст из файла (страница 17)
In vivo antibacterial effects of tretinoin-clindamycin and clindamycinalone on Propionibacterium acnes with varying clindamycin minimum inhibitory /J.J.Leyden // J Drugs Dermatol. – 2012. – V.11. – N.12. – P.1434-8.71.Liden, S. Clinical evaluation in acne / S. Liden, K. Goransson, L.Odsell // ActaDermatovener (Stockholm). – 1980. - Supplement 89. - P. 47-5272.de Lucas, R. Adherence to drug treatments and adjuvant barrier repair therapiesare key factors for clinical improvement in mild to moderate acne: the ACTUOobservational prospective multicenter cohort trial in 643 patients/ R.
de Lucas , G.Moreno-Arias, M. Perez-López, A.Vera-Casaño et al.// BMC Dermatol. – 2015. –V.11. – N.15. – P.17.73.Lucchina, L.C. Fluorescence photography in the evaluation of acne/ L.C.Lucchina, N. Kollias, R.Gillies, S.B. Phillips et al.// J Am Acad Dermatol. – 1996.V.35.
– N.1. – P.58-63.74.Lucky A.W. Double-blind, vehicle-controlled, multicenter comparison of two0.025% tretinoin creams in patients with acne vulgaris/ A.W. Lucky, S.I. Cullen, T.Funicella, M.T. Jarratt et al.// J Am Acad Dermatol. – 1998. – V.38. – N.4. – P.S2430.75.Margolis, D.J. Association of pharyngitis with oral antibiotic use for the treatmentof acne: a cross-sectional and prospective cohort study / D.J. Margolis, M. Fanelli, E.Kupperman, M. Papadopoulos et al.// Arch Dermatol. – 2012.
– V.148. – N.3. –P.326-32.76.Metiko, B. Is the current model for acne pathogenesis backwards? / B. Metiko, K.Brooks, C.G. Burkhart, C.N. Burkhart //J Am Acad Dermatol. – 2015. – V.72. – N.6.– P.e167.77.Mills, O. Jr. Bacterial resistance and therapeutic outcome following three monthsof topical acne therapy with 2% erythromycin gel versus its vehicle / O.
Mills Jr, C.Thornsberry, C.W. Cardin, K.A. Smiles et al.// Acta Derm Venereol. – 2002. – V82.– N.4. – P.260-5.10678.Moradi Tuchayi, S. Interventions to increase adherence to acne treatment / S.Moradi Tuchayi, T.M. Alexander, A. Nadkarni, S.R. Feldman // Patient PreferAdherence. – 2016. – V.11. – N.10. – P.2091-2096.79.Nakase, K. Relationship between the severity of acne vulgaris and antimicrobialresistance of bacteria isolated from acne lesions in a hospital in Japan/ K. Nakase, H.Nakaminami, Y.
Takenaka, N. Hayashi// J Med Microbiol. – 2014. – V.63. – N.Pt 5.– P.721-8.80.Nast, A. European Dermatology Forum.. European evidence-based (S3)guidelines for the treatment of acne / A. Nast, B. Dréno, V. Bettoli, K. Degitz et al.// JEur Acad Dermatol Venereol. – 2012. – V.26.- Suppl 1. - P.1-29.81.Nguyen, C.M. The psychosocial impact of acne, vitiligo, and psoriasis: a review /C.M. Nguyen, K. Beroukhim, M.J. Danesh, A. Babikian et al.// Clin Cosmet InvestigDermatol.
– 2016. – V.20. – N.9. – P.383-392.82.Nishijima, S. The bacteriology of acne vulgaris and antimicrobial susceptibility ofPropionibacterium acnes an Staphylococcus epidermidis isolated from acne lesions /S. Nishijima, I. Kurokawa, N. Katoh, K. Watanabe// J Dermatol. – 2000. – V.27. –N.5. – P.318-23.83.Pacheco, R.L.
Methicillin-resistant Staphylococcus aureus (MRSA) carriage in adermatology unit /R.L. Pacheco ,R.D. Lobo, M.S. Oliveira, E.F. Farina et al.// Clinics(Sao Paulo). – 2011. – V.66. – N.12. – P.2071-7.84.Patel, M. The development of antimicrobial resistance due to the antibiotictreatment of acne vulgaris: a review/ M. Patel, W.P. Bowe, C. Heughebaert, A.R.Shalita // J Drugs Dermatol. – 2010.
– V.9. – N.6. – P.655-64.85.Percival, S.L. Microbiology of the skin and the role of biofilms in infection / S.L.Percival, C. Emanuel, K.F. Cutting, D.W. Williams // Int Wound J. – 2012. – V.9. –N.1. – P.14-32.86.Pochi, P.E. Report of the Consensus Conference on Acne Classification.Washington, D.C., March 24 and 25, 1990/ P.E.
Pochi, A.R. Shalita, J.S. Strauss,S.B. Webster et al. // J Am Acad Dermatol. – 1991. – V.24- N.3. – P.495-500.10787.Prasad, S. Efficacy and safety of a nano-emulsion gel formulation of adapalene0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label,active-controlled, multicentric, phase IV clinical trial/ S. Prasad, A. Mukhopadhyay,A. Kubavat, A.
Kelkar et al.// Indian J Dermatol Venereol Leprol. – 2012.- V.78. –N.4. – P.459-67.88.Ramli, R. Acne analysis, grading and computational assessment methods: anoverview/ R. Ramli, A.S. Malik, A.F. Hani, A. Jamil et al.// Skin Res Technol. –2012. – V.18. – N.1.
– P.1-14.89.Rapp, D.A. Anger and acne: implications for quality of life, patient satisfactionand clinical care/ D.A. Rapp, G.A. Brenes, S.R. Feldman, A.B. Fleischer Jr et al.// BrJ Dermatol. – 2004. – V.151. – N.1. – P.183-9.90.Revol, O. Psychological impact of acne on 21st-century adolescents: decoding forbetter care/ O. Revol, N. Milliez, D. Gerard// Br J Dermatol. – 2015. – V.172. - Suppl1. –P.52-8.91.Richter, C. Follicular fluorescence quantity to characterize acne severity: avalidation study/ С.
Richter // Skin Research and Technology. – 2016. – N22. - T4. –C. 451-459.92.Rigopoulos, D. Comparison of topical retinoids in the treatment of acne / D.Rigopoulos, D. Ioannides, D. Kalogeromitros, A.D. Katsambas // Clin Dermatol2004Sep-Oct;22(5):408-11.93.Rizova, E.
Polarized light photography and videomicroscopy greatly enhance thecapability of estimating the therapeuic response to a topical retinoid (adapalene) inacne vulgaris/ E. Rizova, P.A. Pagnoni PA, T. Stoudemayer, M. Poncet et al.// Cutis.– 2001. – V.68. – 4 Suppl. – P.25-33.94.Rosen, T. Antibiotic resistance: an editorial review with recommendations/ T.Rosen// J Drugs Dermatol. – 2011.
–V.10. – N.7. – P.724-33.95.Ross, J.I. Antibiotic-resistant acne: lessons from Europe/ J.I. Ross, A.M. Snelling,E. Carnegie, P. Coates et al.// Br J Dermatol. – 2003. – V.148. – N.3. – P.467-78.96.Sardana,K.Cross-sectionalPilotStudy ofAntibioticResistanceinPropionibacterium Acnes Strains in Indian Acne Patients Using 16S-RNA108Polymerase Chain Reaction: A Comparison Among Treatment Modalities IncludingAntibiotics, Benzoyl Peroxide, and Isotretinoin/ K. Sardana,T. Gupta, B. Kumar,H.K. Gautam et al.// Indian J Dermatol. – 2016. – V.61.
–N.1. –P.45-52.97.Schafer, F. Antimicrobial susceptibility and genetic characteristics ofPropionibacterium acnes isolated from patients with acne/ F. Schafer,F. Fich, M.Lam, C. Gárate//. Int J Dermatol. – 2013. – V.52. – N.4- P.418-25.98.Seidler, E.M.
Meta-analysis comparing efficacy of benzoyl peroxide,clindamycin, benzoyl peroxide with salicylic acid, and combination benzoylperoxide/ clindamycin in acne/ E.M. Seidler, A.B. Kimball // J Am Acad Dermatol. –2010. -N.63. – P.52-62.99.Shaheen, B. Acne sans С. acnes. / B. Shaheen, M. Gonzalez // J Eur AcadDermatol Venereol. – 2013. – V.27. – N.1. – P.1-10.100. Shalita, A. A comparison of the efficacy and safety of adapalene gel 0.1% andtretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial/ A.
Shalita,J.S. Weiss, D.K. Chalker, C.N. Ellis et al. // J Am Acad Dermatol. – 1996.-V.34. –N.3. – P.482-5.101. Snyder, S. Medical adherence to acne therapy: a systematic review/ S. Snyder, I.Crandell, S.A. Davis, S.R.Feldman // Am J Clin Dermatol.
– 2014. – V.15. – N.2. –P.87-94.102. Strauss, J.S. Guidelines of care for acne vulgaris management/ J.S. Strauss, D.P.Krowchuk, J.J. Leyden, A.W. Lucky et al.// J Am Acad Dermatol. – 2007. – V.56. –N.4. – P.651-63.103. Tan, J.K. Effect of quality of life impact and clinical severity on adherence totopical acne treatment/ J.K.Tan, M.Balagurusamy, K.Fung et al.
// J Cutan Med Surg.– 2009. – V.13. – N.4. – P. 204—208.104. Tanghetti, E.A. The noncompliant patient with acne/ E.A. Tanghetti// SkinTherapy Lett. – 2011. – V.16.- N.10. – P.4-5.105. Tanghetti, E.A. The role of inflammation in the pathology of acne/ E.A.Tanghetti//.
J Clin Aesthet Dermatol. – 2013. – V.6. – N.9.- P.27-35.109106. Thiboutot, D. Acne counseling to improve adherence/ D. Thiboutot, B. Dréno, A.Layton //. Cutis. – 2008.- V.81.- N.1.- P.81-6.107. Thiboutot, D. Global Alliance to Improve Outcomes in Acne.. New insights intothe management of acne: an update from the Global Alliance to Improve Outcomes inAcne group/ D. Thiboutot, H. Gollnick, V.
Bettoli, B. Dréno et al.// J Am AcadDermatol. – 2009. – V.60. - 5 Suppl. – P.S1-50.108. Thomas, H.D. Psychosocial Effects of acne/ H.D.Thomas // J Cutan Med Surg. 2004. – N.8. – P.3-5.109. Toyne, H. Propionibacterium acnes (P. acnes) resistance and antibiotic use inpatients attending Australian general practice/ H. Toyne, C. Webber, P. Collignon, K.Dwan et al. // Australas J Dermatol. – 2012. – V.53. – N.2. – P.106-11.110. Tuchin, V.V. A pilot study of ICG laser therapy of acne vulgaris: photodynamicand photothermolysis treatment/ V.V.
Tuchin, E.A. Genina, A.N. Bashkatov, G.V.Simonenko et al/ // Lasers Surg Med. – 2003. – V.33. – N.5. – P.296-310.111. Walsh, T.R. Systematic review of antibiotic resistance in acne: an increasingtopical and oral threat/ T.R. Walsh, J. Efthimiou, B. Dréno // Lancet Infect Dis.
–2016. – V.16.- N.3. – P.e23-33.112. Wang,Y. Staphylococcus epidermidis in the human skin microbiome mediatesfermentation to inhibit the growth of Propionibacterium acnes: implications ofprobiotics in acne vulgaris/ Y. Wang, S.Kuo, M. Shu, A. Yu et al. // Appl MicrobiolBiotechnol. – 2014. – V.98. – N.1. - P.411-24.113. Warren, R. Staphylococcus aureus--a cross sectional study of prevalence and riskfactors in one general practice/ R. Warren// Aust Fam Physician.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
